Pediatrics Congress 2018

Recent advancements in Pediatriccancer are minimal residual disease (MRD) assays. It help to detect cells harboring molecular changes specific to leukemia with a sensitivity of up to 1. To know more advancements in Pediatric cancer meet our eminent peronalities in Pediatric Congress 2018
Further details visit: https://bit.ly/2JywddP



Comments

Popular posts from this blog

Pediatrics Congress 2018

Pediatrics Congress 2018

Pediatrics Congress 2018